A team led by University of Toronto researchers has discovered a new communication pathway between the gut and lung.

Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...

III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary sequelae of COVID-19.